Breast Cancer Education to Prisoner Women

Breast Cancer Clinical Trial

Official title:

The Effect of Breast Cancer Education Given to Prisoner Women on Breast Cancer Knowledge and Awareness

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06455657
• Other study ID #: Hitit_university_1
• Status: Recruiting
• Phase: N/A
• Start date: May 24, 2024
• Est. completion date: August 15, 2024

Study information

• Verified date: June 2024
• Source: Hitit University
• Contact: Fatma Yildirim, Dr
• Phone: 05466742445
• Email: fatmadmryldrm[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of the study is to determine the effect of breast cancer education given to incarcerated women on breast cancer knowledge and awareness.

Description:

Breast cancer is the most common cancer among women in the world, accounting for almost a quarter of cancer cases diagnosed among women, with 1.15 million cases diagnosed each year. Breast cancer is common in both developed and developing countries. However, in developing countries, these rates are three times higher and the mortality rate is quite high. Risk factors include age, low socioeconomic level, early menarche, late menopause, family history of breast disease, long-term use of hormone replacement therapy, breastfeeding status and lifestyle habits.

It is reported that breast cancer screening programs such as mammography, breast self-examination (BSE) and clinical breast examination (CMM) have an important role in early diagnosis, increasing the survival rate, reducing the death rate and preventing relapse in breast cancer patients. It has been reported that women who perform regular BSE are more likely to have early stages of the disease, this is because regular BSE gives the woman information about the feel and appearance of the breast. Thus, the woman will be able to detect any changes as early as possible. It is reported that the practice of breast self-examination depends on different factors, including women's knowledge, attitude, socio-demographic and sociocultural factors. Other reasons for low implementation rates, such as lack of time, forgetfulness, and low education level, have also been reported.

Breast cancer is the second leading cause of death after cervical cancer among incarcerated women under the age of 40. 27% of women over the age of 40 had breast cancer, and 18% of these women died. It is of great importance to raise awareness, which is considered one of the main elements of secondary prevention in breast cancer.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 40
• Est. completion date: August 15, 2024
• Est. primary completion date: July 15, 2024
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Volunteering to participate in the study,

• Being between the ages of 18-65,

• No history of breast cancer,

• To know Turkish.

Exclusion Criteria:

• Those who do not agree to participate in the study,

• Having a history of breast cancer,

• Those who do not speak Turkish

Related Conditions & MeSH terms

• Breast Cancer
• Breast Neoplasms

Intervention

Other:
• breast cancer education
Questionnaires and scales will be administered to the participants as a pre-test. Breast cancer education will be provided in groups and their feedback will be received. Reminder training will be repeated 1 month after the training. The survey and scales will be administered to the participants as a posttest 1 month after the second training.

Locations

Country	Name	City	State
Turkey	Hitit university	Corum
Turkey	Fatma Yildirim	Çorum	Corum
Turkey	L type prison	Çorum

Sponsors (1)

Lead Sponsor	Collaborator
Hitit University

Country where clinical trial is conducted

Turkey, 

References & Publications (7)

American Cancer Society. Breast Cancer Information & Overview. 2023. Available from: https://www.cancer.org/cancer/types/breast-cancer.html

Bas, S., Ursavas, F.(2022). Meme Kanseri Farkindalik Ölçeginin Geçerlilik ve Güvenilirligi, Çankiri Karatekin Üniversitesi Saglik Bilimleri Enstitüsü Hemsirelik Anabilim Dali, Yüksek Lisans Tezi

Black E, Richmond R. Improving early detection of breast cancer in sub-Saharan Africa: why mammography may not be the way forward. Global Health. 2019 Jan 8;15(1):3. doi: 10.1186/s12992-018-0446-6. — View Citation

Choi JS, Park M. Factors predicting young women's willingness to conduct vulvar self-examinations in Korea. Health Care Women Int. 2019 Jun;40(6):653-664. doi: 10.1080/07399332.2018.1531003. Epub 2018 Dec 14. — View Citation

Jemal A, Bray F, Forman D, O'Brien M, Ferlay J, Center M, Parkin DM. Cancer burden in Africa and opportunities for prevention. Cancer. 2012 Sep 15;118(18):4372-84. doi: 10.1002/cncr.27410. Epub 2012 Jan 17. — View Citation

Mohamed, A. O. A., Nori, M. M. M., & Altamih, R. A. A. (2021). The Effectiveness of Breast Cancer Health Education Campaign and Breast Self-Examination Training among Female Detainees, Khartoum City-Sudan. Journal of Environmental Science and Public Health, 5(2), 296-310

Saadeldin A. Idris, Aamir A. Hamza, Mohamed M. Hafiz, Mohammed Eltayeb A. Ali, Gamal E. H. A., El Shallaly Knowledge, attitude and practice of breast self examination among final years female medical students in Sudan. Int J Public Health Res 2013;1:6-10

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Breast Cancer Awareness Scale	It was developed in 2010 by the UK cancer research center, "King's College London" and "University College London" to raise breast cancer awareness. In our country, the Turkish validity and reliability study of the scale was conducted by Bas and Ursavas (2022). The scale consists of a total of 13 items to determine breast cancer awareness, including symptoms (11 items), frequency of breast examination (1 item) and breast cancer age (1 item). The scale has no cut-off point. Answering 5 of the symptoms correctly is coded as 1 point, a 70-year-old woman is coded as 1 point, and breast examination once a month is coded as 1. Incorrect answers are worth 0 points. Scoring is between 0-3. Cronbach's alpha value of the scale was found to be 0.89. As the score obtained from the scale increases, breast cancer awareness increases (Bas and Ursavas, 2022).	first-2. months
Secondary	Comprehensive Breast Cancer Knowledge Test	Comprehensive Breast Cancer Information was developed by Stager in 1993 (Stager, 1993). The scale included a total of 20 knowledge questions. Scale; It is answered as True or False. There were 8 correct and 12 incorrect statements in the questions. The alpha value of the general knowledge dimension was .60; The alpha value of the treatability subscale was found to be .62 and the total of the scale was found to be .71 (Stager, 1993). The scale was adapted to Turkish by Basak (2015). Basak is the sub-dimension and total Cronbach's alpha coefficient of the scale; .65, .50 for General Knowledge, Treatability, and Scale Total scores, respectively. and found .67.	first- 2. months